...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

Without getting into too many off-topic details, what is Zenith giving up to Newsora for their involvement?

And why is Zenith securing partners but not Resverlogix?

Share
New Message
Please login to post a reply